0001839990 false 0001839990 2022-09-02
2022-09-02 0001839990
ARTEU:UnitsEachConsistingOfOneShareOfClassCommonStockAndOnehalfOfOneRedeemableWarrantMember
2022-09-02 2022-09-02 0001839990 us-gaap:CommonClassAMember
2022-09-02 2022-09-02 0001839990
ARTEU:WarrantsEachWholeWarrantExercisableForOneShareOfClassCommonStockEachAtExercisePriceOf11.50PerShareMember
2022-09-02 2022-09-02 iso4217:USD xbrli:shares iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported):
September 2, 2022
ARTEMIS STRATEGIC INVESTMENT CORPORATION
(Exact name of registrant as specified in its charter)
Delaware |
001-40855 |
86-1303512 |
(State or other jurisdiction
of incorporation) |
(Commission
File Number) |
(IRS Employer
Identification No.) |
3310 East Corona Avenue
Phoenix,
Arizona
85040
(Address of principal executive offices, including zip code)
Registrant’s telephone number, including area code: (602)
346-0329
Not Applicable
(Former name or former address, if changed
since last report)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
x |
Written communications pursuant to Rule 425 under
the Securities Act (17 CFR 230.425) |
¨ |
Soliciting material pursuant to Rule 14a-12 under
the Exchange Act (17 CFR 240.14a-12) |
¨ |
Pre-commencement communications pursuant to Rule
14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
¨ |
Pre-commencement communications pursuant to Rule
13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
Title of each
class |
|
Trading Symbol(s) |
|
Name of each exchange on which
registered |
Units, each consisting of one share of
Class A common stock and one-half of one redeemable
warrant |
|
ARTEU |
|
The Nasdaq Stock Market LLC |
Class A common stock, par value $0.0001
per share |
|
ARTE |
|
The Nasdaq Stock Market LLC |
Warrants, each whole warrant exercisable
for one share of Class A common stock, each at an exercise price of
$11.50 per share |
|
ARTEW |
|
The Nasdaq Stock Market LLC |
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933
(§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange
Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
x
If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act.
Item
1.01. Entry into a Material Definitive Agreement.
Amendment No. 1 to the Merger Agreement
As
previously disclosed, on March 30, 2022, Artemis
Strategic Investment Corporation, a Delaware corporation
(“Artemis,” “we,” “us,” “our” or the “Company”), entered into an
agreement and plan of reorganization, with Komisium Limited, a
private company limited by shares incorporated under the laws of
Cyprus and the sole equityholder of Novibet (“Komisium”), Logflex
MT Holding Limited, a limited liability company organized under the
laws of Malta with company registration number C 77769 and having
its registered office at 170, Pater House, Level 1
(Suite A191), Psaila Street, Birkirkara, BKR 9077, Malta and a
direct, wholly-owned subsidiary of Komisium (“Novibet”), Novibet
PLC, a United Kingdom public limited company, and a direct,
wholly-owned subsidiary of Komisium (“PubCo”), and Novibet Merger
Sub Inc., a Delaware corporation and a direct, wholly-owned
subsidiary of PubCo (“Merger Sub”) (the “Merger Agreement”). The
Merger Agreement and the transactions contemplated thereby (the
“Business Combination”) were unanimously approved by Artemis’ board
of directors on March 28, 2022.
On September 2, 2022, the parties to the Merger Agreement entered
into Amendment No. 1 to the Merger Agreement (the
“Amendment”). The Amendment amends the Merger Agreement and certain
related agreements to, among other things:
|
• |
reduce the value of the closing
consideration payable to Komisium in the transaction from
$625,000,000 to $500,000,000; provided that if redemptions are
equal to or exceed 85% of Artemis’ total public shares outstanding,
then Komisium will be issued additional share consideration valued
at $125,000,000; |
|
• |
reduce the amount of cash required
to be available to Novibet at the closing of the Business
Combination from $50,000,000 in gross cash after payment to
redeeming stockholders to $12,500,000 in net cash after payment to
redeeming stockholders and transaction expenses; |
|
• |
alter the earn-out structure from a
single tranche of earnout shares payable if a stock price target is
met to dual tranches payable if certain operating targets based on
Net Gaming Revenue are met; |
|
• |
release the post-closing lockup on
30% of the ordinary shares of PubCo (the “PubCo Ordinary Shares”)
to be issued to Komisium in the Business Combination; and |
|
• |
allow Novibet to pay a pre-closing
dividend to Komisium in the amount of €3,579,625, which was
declared prior to March 30, 2022 but has not yet been paid or
distributed; provided, that at Komisium’s election, such dividend
may be paid through a non-interest bearing note with a maturity
date as of the one year anniversary of the distribution date. |
The foregoing description of the Amendment does not purport to be
complete and is qualified in its entirety by the terms of the
Amendment, a copy of which is attached as Exhibit 2.1 hereto
and is incorporated by reference herein.
Important Information About the Proposed Business Combination
and Where to Find It
In connection with the proposed Business Combination, Artemis,
Novibet, and PubCo intend to prepare, and PubCo intends to file
with the SEC a registration statement on Form F-4 (the
“Registration Statement”), which will contain the proxy statement
of Artemis and the prospectus of PubCo (as amended or supplemented
from time to time, the “Proxy Statement/Prospectus”), one or more
amendments to the Registration Statement, and, after the
Registration Statement is declared effective, Artemis will mail the
definitive Proxy Statement/Prospectus included therein to the
holders of Artemis’s common stock in connection with Artemis’s
solicitation of proxies for the vote by Artemis stockholders with
respect to the Business Combination and other matters described in
the Registration Statement. Artemis urges its stockholders and
other interested persons to read, when available, the Registration
Statement, the amendments thereto, and the documents incorporated
by reference therein, as well as other documents filed by Artemis
and PubCo with the SEC in connection with the Business Combination,
as these materials will contain important information about
Artemis, Novibet, and the Business Combination. Stockholders of
Artemis will also be able to obtain copies of such documents, when
available, free of charge through the website maintained by the SEC
at www.sec.gov or by directing a written request to Artemis
Strategic Investment Corporation, 3310 East Corona Avenue, Phoenix,
AZ 85040.
Participants in the Solicitation
Under SEC rules, Artemis, Novibet, PubCo, and its and their
respective officers and directors may be deemed to be participants
in the solicitation of Artemis’s stockholders in connection with
the Business Combination. Stockholders of Artemis may obtain more
detailed information regarding the names, affiliations, and
interests of Artemis’s directors and officers in Artemis’s final
prospectus for its initial public offering, filed with the SEC on
October 1, 2021 (the “IPO Prospectus”), and the Registration
Statement, when available. The interests of Artemis’s directors,
officers, and others in the Business Combination may, in some
cases, be different than those of Artemis’s stockholders generally.
Information about such interests will be set forth in the
Registration Statement when it becomes available. You may obtain
free copies of these documents as described in the preceding
paragraph.
Forward-Looking Statements
This Current Report on Form 8-K and the exhibits hereto
include historical information as well as “forward-looking
statements” within the meaning of the “safe harbor” provisions of
the Private Securities Litigation Reform Act of 1995. These
forward-looking statements are included throughout this Current
Report on Form 8-K and the exhibits hereto and relate to
matters such as the future results of operations and financial
position of PubCo and its subsidiaries; planned products and
services; Novibet’s business strategy, including Novibet’s planned
launch in the United States and North America; objectives of
Novibet’s management for future operations; market size and
potential growth opportunities; competitive position; expectations
and timings related to commercial launches; potential benefits of
the proposed Business Combination; and technological and market
trends and other future conditions.
Words such as “expect,” “estimate,” “project,” “budget,”
“forecast,” “future,” “anticipate,” “assume,” “intend,” “plan,”
“may,” “will,” “could,” “should,” “would,” “believes,” “predicts,”
“potential,” “strategy,” “opportunity,” “continue,” and similar
expressions are intended to identify such forward-looking
statements. Accordingly, such forward-looking statements are not
guarantees and are subject to inherent risks, uncertainties, and
changes in circumstance that are difficult to predict and may be
outside of PubCo’s, Artemis’s and Novibet’s control. PubCo’s,
Artemis’s and Novibet’s actual results may differ materially from
their expectations, estimates and projections due to a variety of
factors and consequently, you should not place undue reliance on
these forward-looking statements as predictions of future events.
Although it is impossible to identify all factors that may cause
such differences, they include, but are not limited to:
(1) the level of redemptions by Artemis’s shareholders in
connection with the Business Combination and the outcome of any
legal proceedings that may be instituted against Artemis or Novibet
following the announcement of the Business Combination;
(2) the inability to complete the Business Combination;
(3) delays in obtaining, adverse conditions contained in, or
the inability to obtain any necessary regulatory approvals or
complete regulatory reviews required to complete the Business
Combination; (4) the risk that the Business Combination
disrupts current plans and operations of Novibet as a result of the
announcement and consummation of the Business Combination;
(5) the inability to recognize the anticipated benefits of the
Business Combination, which may be affected by, among other things,
competition, the ability of the combined company to grow and manage
growth profitably, maintain relationships with customers and
suppliers and retain its key employees; (6) costs related to
the Business Combination; (7) changes in laws or regulations
applicable to Novibet’s business and Novibet’s ability to comply
with such laws and regulations; (8) the possibility that PubCo
may be adversely affected by other economic, business, and/or
competitive factors; (9) the impact of the global COVID-19
pandemic on Novibet’s business; (10) the risk factors which
will be set forth under the heading “Risk Factors” in the
Registration Statement; and (11) the risks and uncertainties
described in the “Risk Factors” section of Artemis’s IPO Prospectus
and Artemis’s and PubCo’s subsequent filings with the SEC.
The foregoing list of factors is not exclusive. There may be
additional risks that Artemis and Novibet do not presently know or
that they currently believe are immaterial that could cause actual
results to differ materially from those contained in the
forward-looking statements. All information set forth herein speaks
only as of the date hereof in the case of information about Artemis
and Novibet or the date of such information in the case of
information from persons other than Artemis and Novibet, and PubCo,
Artemis and Novibet expressly disclaim any intention or obligation
to update any forward-looking statements as a result of
developments occurring after the date of this Current Report on
Form 8-K or to reflect any changes in their expectations or
any change in events, conditions or circumstances on which any
statement is based.
No Offer or Solicitation
This Current Report on Form 8-K and the exhibits hereto are
for informational purposes only and shall neither constitute an
offer to sell nor the solicitation of an offer to buy any
securities, nor a solicitation of a proxy, vote, consent or
approval in any jurisdiction in connection with the Business
Combination, nor shall there be any sale of securities in any
jurisdiction in which the offer, solicitation or sale would be
unlawful prior to the registration or qualification under the
securities laws of any such jurisdictions. No offering of
securities shall be made except by means of a prospectus meeting
the requirements of Section 10 of the Securities Act, or an
exemption therefrom.
Item
9.01. Financial
Statements and Exhibits.
(d) Exhibits.
Exhibit
Number |
|
Description |
2.1 |
|
Amendment
No. 1, dated September 2, 2022, to the Agreement and Plan of
Reorganization, dated as of March 30, 2022, by and among
Artemis Strategic Investment Corporation, Komisium Limited, Logflex
MT Holding Limited, Novibet PLC, and Novibet Merger Sub
Inc. |
104 |
|
Cover
Page Interactive Data File (formatted as inline XBRL and
contained in Exhibit 101) |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on
its behalf by the undersigned hereunto duly authorized.
|
ARTEMIS
STRATEGIC INVESTMENT CORPORATION |
|
|
|
|
By: |
/s/ Thomas
Granite |
|
Name: |
Thomas
Granite |
|
Title: |
Chief
Financial Officer |
Date:
September 9, 2022 |
|
|
Artemis Strategic Invest... (NASDAQ:ARTEU)
Historical Stock Chart
From Feb 2023 to Mar 2023
Artemis Strategic Invest... (NASDAQ:ARTEU)
Historical Stock Chart
From Mar 2022 to Mar 2023